Aneuscreen offers groundbreaking insights into the pathogenesis of brain aneurysms. The company has developed a revolutionary, cost-effective, and highly accurate diagnostic exam designed to predict the future formation of cerebral aneurysms using advanced computer vision (AI) techniques. This "once-in-a-lifetime" exam also detects existing aneurysms at an early stage (less than 4mm), addressing the common issue of small aneurysms being overlooked by radiologists. By detecting these early, Aneuscreen saves lives and reduces the economic burden associated with severe outcomes from aneurysm ruptures, such as subarachnoid hemorrhage (SAH).
The solution functions both as a decision support tool for aneurysm detection and as a classifier for identifying individuals susceptible to aneurysm development, using morphology analysis of the brain's arterial tree.
It can be integrated with any neuroimaging modality that visualizes vascular structures.
Company Details
- Founded
- -
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://www.aneuscreen.com
- Keywords
- ADAM CogTec.
Aneuscreen Questions
Aneuscreen's website is https://www.aneuscreen.com
Aneuscreen's LinkedIn profile is https://www.linkedin.com/company/aneuscreen
Aneuscreen's industry is
Hospitals and Health Care
Aneuscreen's top competitors are
Anicca Health,
Avertto,
Amygdala,
Actualsignal,
Arrows,
Arctop,
1e Therapeutics,
Elda Ai,
Adam Cogtec,
Algosensus.
Aneuscreen's categories are Hospitals and Health Care
Aneuscreen's founding year is 2017
